2021 FDA Pom Zoo Tshuaj Tshiab 1Q-3Q

Kev tsim kho tshiab ua rau muaj kev vam meej.Thaum nws los txog rau kev tsim kho tshiab hauv kev tsim cov tshuaj tshiab thiab cov khoom siv tshuaj lom neeg, FDA's Center for Drug Evaluation and Research (CDER) txhawb kev lag luam tshuaj ntawm txhua kauj ruam ntawm cov txheej txheem.Nrog rau nws txoj kev nkag siab txog kev tshawb fawb siv los tsim cov khoom tshiab, kev sim thiab cov txheej txheem tsim khoom, thiab cov kab mob thiab cov xwm txheej uas cov khoom tshiab tau tsim los kho, CDER muab cov lus qhia txog kev tshawb fawb thiab kev tswj hwm xav tau los coj cov kev kho tshiab rau kev ua lag luam.
Kev muaj cov tshuaj tshiab thiab cov khoom siv roj ntsha feem ntau txhais tau tias kev kho mob tshiab rau cov neeg mob thiab kev nce qib hauv kev kho mob rau pej xeem Asmeskas.Vim li no, CDER txhawb nqa kev tsim kho tshiab thiab ua lub luag haujlwm tseem ceeb hauv kev pab txhawb kev txhim kho tshuaj tshiab.
Txhua xyoo, CDER pom zoo ntau yam tshuaj tshiab thiab cov khoom siv roj ntsha:
1. Qee yam ntawm cov khoom no yog cov khoom tshiab tshiab uas tsis tau siv rau hauv kev kho mob.Hauv qab no yog cov npe ntawm cov koom haum tshiab molecular thiab cov khoom siv kho mob tshiab tau pom zoo los ntawm CDER hauv 2021. Cov npe no tsis muaj cov tshuaj tiv thaiv, cov khoom ua xua, cov ntshav thiab cov ntshav, cov ntshav plasma derivatives, cellular thiab noob kho cov khoom, lossis lwm yam khoom tau pom zoo hauv 2021 los ntawm lub Center for Biologics Evaluation and Research.
2. Lwm tus yog tib yam li, lossis cuam tshuam nrog, cov khoom tau pom zoo yav dhau los, thiab lawv yuav sib tw nrog cov khoom lag luam hauv khw.Saib Drugs@FDA kom paub txog txhua yam ntawm CDER cov tshuaj pom zoo thiab cov khoom siv roj ntsha.
Qee cov tshuaj raug cais raws li cov chaw tshiab molecular ("NMEs") rau lub hom phiaj ntawm FDA tshuaj xyuas.Ntau yam ntawm cov khoom no muaj cov active moieties uas tsis tau pom zoo los ntawm FDA yav tas los, xws li ib yam tshuaj muaj los yog raws li ib feem ntawm cov khoom ua ke;cov khoom no nquag muab cov kev kho tshiab tseem ceeb rau cov neeg mob.Qee cov tshuaj muaj tus cwj pwm zoo li NMEs rau kev tswj hwm lub hom phiaj, tab sis txawm li cas los xij muaj cov moieties uas muaj feem cuam tshuam nrog kev ua haujlwm moieties hauv cov khoom uas yav dhau los tau pom zoo los ntawm FDA.Piv txwv li, CDER faib cov khoom siv roj ntsha xa mus rau hauv daim ntawv thov raws li Tshooj 351 (a) ntawm Public Health Service Act raws li NMEs rau lub hom phiaj ntawm FDA tshuaj xyuas, txawm hais tias lub koom haum yav dhau los tau pom zoo muaj feem cuam tshuam rau cov khoom sib txawv.FDA qhov kev faib tawm ntawm cov tshuaj raws li "NME" rau kev tshuaj xyuas yog txawv ntawm FDA qhov kev txiav txim siab ntawm seb cov khoom siv tshuaj puas yog "cov tshuaj tshiab" lossis "NCE" nyob rau hauv lub ntsiab lus ntawm Tsoom Fwv Teb Chaws Khoom Noj, Tshuaj, thiab Tshuaj pleev ib ce.

Tsis muaj. Tshuaj npe Cov khoom xyaw nquag Hnub pom zoo FDA pom zoo siv rau hnub pom zoo *
37 Exkivity mobocertinib 9/15/2021 Txhawm rau kho cov mob qog noj ntshav hauv zos lossis metastatic uas tsis yog mob qog noj ntshav me me nrog cov kab mob epidermal loj hlob receptor exon 20 qhov kev hloov pauv
36 Skytrofa Lonapegsomatropin-tcgd 8/25/2021 Txhawm rau kho luv stature vim tsis txaus tso tawm ntawm endogenous loj hlob hormone
35 Korsuva difelikefalin 8/23/2021 Txhawm rau kho mob me me-rau-mob pruritus cuam tshuam nrog mob raum mob hauv qee cov neeg
34 Welireg belzutifan ua 8/13/2021 Txhawm rau kho tus kab mob von Hippel-Lindau hauv qee yam mob
33 Nexviazyme avalglucosidase alfa-ngpt 8/6/2021 Txhawm rau kho tus kab mob Pompe lig
Xovxwm tshaj tawm
32 Saphnelo anifrolumab-fnia 7/30/2021 Txhawm rau kho qhov nruab nrab-rau qhov hnyav rau lub cev lupus erythematousus nrog rau kev kho tus qauv
31 Bylvay odevixibat 7/20/2021 Kho pruritus
30 Rezurock belumosudil 7/16/2021 Txhawm rau kho cov kab mob ntev-tiv thaiv-tus tswv tsev tom qab tsis ua haujlwm tsawg kawg ob kab ua ntej ntawm kev kho mob
29 fexinidazole fexinidazole 7/16/2021 Txhawm rau kho tib neeg African trypanosomiasis tshwm sim los ntawm tus kab mob Trypanosoma brucei gambiense
28 Kerendia zoorenone 7/9/2021 Txhawm rau txo qhov kev pheej hmoo ntawm mob raum thiab mob plawv hauv cov kab mob raum ntev uas cuam tshuam nrog hom 2 mob ntshav qab zib
27 Rylaze asparaginase erwinia chrysanthemi (recombinant)-rywn 6/30/2021 Txhawm rau kho tus mob lymphoblastic leukemia thiab lymphoblastic lymphoma nyob rau hauv cov neeg mob uas tsis haum rau E. coli-derived asparaginase cov khoom, raws li ib feem ntawm cov tshuaj kho mob.
Xovxwm tshaj tawm
26 Aduhelm aducanumab-avwa 6/7/2021 Yuav kho Alzheimer's disease
Xovxwm tshaj tawm
25 Brexafemme ibrexafungerp 6/1/2021 Txhawm rau kho vulvovaginal candidiasis
24 Lybalvi olanzapine thiab samidorphan 5/28/2021 Txhawm rau kho tus mob schizophrenia thiab qee yam ntawm kev puas siab puas ntsws bipolar I
23 Truseltiq infigratinib 5/28/2021 Txhawm rau kho tus mob cholangiocarcinoma uas nws tus kab mob ua tau raws li cov txheej txheem
22 Lumakras sotorasib 5/28/2021 Txhawm rau kho hom mob qog noj ntshav uas tsis yog me me
Xovxwm tshaj tawm
21 Pylarify Piflufolastat F 18 5/26/2021 Txhawm rau txheeb xyuas prostate-specific membrane antigen-positive lesions hauv prostate cancer
20 Rybrevant amivantamab-vmjw 5/21/2021 Txhawm rau kho cov kab mob qog noj ntshav uas tsis yog me me
Xovxwm tshaj tawm
19 Empaveli pegcetacoplan 5/14/2021 Txhawm rau kho paroxysmal nocturnal hemoglobinuria
18 Zynlonta loncastuximab tesirine-lpyl 4/23/2021 Txhawm rau kho qee yam mob rov qab los yog refractory loj B-cell lymphoma
17 Jemperli dostarlimab-gxly 4/22/2021 Yuav kho mob qog noj ntshav endometrial
Xovxwm tshaj tawm
16 Nextstellis drospirenone thiab estetrol 4/15/2021 Txhawm rau tiv thaiv kev xeeb tub
15 Qelbree tshuaj viloxazine 4/2/2021 Txhawm rau kho qhov tsis txaus siab hyperactivity teeb meem
14 Zegalogue dasiglucagon 3/22/2021 Kev kho mob hnyav hypoglycemia
13 Ponvory ponesimod 3/18/2021 Txhawm rau kho cov ntaub ntawv rov qab ntawm ntau yam sclerosis
12 Fotivda tiv 3/10/2021 Yuav kho lub raum cell carcinoma
11 Azstarys serdexmethylphenidate thiab 3/2/2021 Txhawm rau kho qhov tsis txaus siab hyperactivity teeb meem
dexmethylphenidate
10 Pepaxto melphalan flufenamide 2/26/2021 Kev kho mob rov qab los yog refractory ntau myeloma
9 Nulibry fosdenopterin nyob rau hauv cov ntshav 2/26/2021 Txhawm rau txo qhov kev pheej hmoo ntawm kev tuag hauv molybdenum cofactor deficiency Hom A
Xovxwm tshaj tawm
8 Amondys 45 casmersen 25/2/2021 Yuav kho Duchenne muscular dystrophy
Xovxwm tshaj tawm
7 Cosela trilacicilib 2/12/2021 Txhawm rau txo cov tshuaj tua kab mob vim yog myelosuppression hauv cov qog nqaij hlav me me
Xovxwm tshaj tawm
6 Evkeeza evinacumab-dgnb 2/11/2021 Txhawm rau kho homozygous tsev neeg hypercholesterolemia
5 Ukoniq umbralisib 2/5/2021 Txhawm rau kho marginal zone lymphoma thiab follicular lymphoma
4 Tepmetko tepotin ib 2/3/2021 Txhawm rau kho mob qog noj ntshav tsis yog me me
3 Lupkynis voclosporin 1/22/2021 Txhawm rau kho lupus nephritis
Drug Trials Snapshot
2 Cabenuva cabotegravir thiab rilpivirine (co-packaged) 1/21/2021 Kho HIV
Xovxwm tshaj tawm
Drug Trials Snapshot
1 Verquvo vericiguat 1/19/2021 Txhawm rau txo qhov kev pheej hmoo ntawm cov hlab plawv tuag thiab mus pw hauv tsev kho mob rau lub plawv tsis ua haujlwm ntev
Drug Trials Snapshot

 

Cov npe "FDA-pom zoo siv" ntawm lub vev xaib no yog rau kev nthuav qhia nkaus xwb.Txhawm rau pom FDA-pom zoo rau kev siv [piv txwv li, cov lus qhia, cov pej xeem, kev siv tshuaj noj] rau txhua yam ntawm cov khoom no, saib cov ntaub ntawv sau tshuaj uas nyuam qhuav pom zoo los ntawm FDA.
Cite los ntawm FDA lub vev xaib:Tsab ntawv xov xwm no tshwm sim thawj zaug https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021


Post lub sij hawm: Sep-27-2021